Seeking Alpha

Amgen (AMGN -0.2%) announces that it has struck an agreement with the FDA to modify its Nplate...

Amgen (AMGN -0.2%) announces that it has struck an agreement with the FDA to modify its Nplate treatment designed to treat an immune system disorder that attacks blood elements. "The FDA has now concluded that enrollment in a restricted distribution program is no longer necessary to prescribe or receive Nplate."
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|